LogicBio Therapeutics, Inc. LOGC was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.41 to $7.00 in the past one-month time frame.
The company has seen one positive estimate revision in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for LogicBio Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
LogicBio Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
LogicBio Therapeutics, Inc. Price
A better-ranked stock in the Medical – Biomedical and Genetics industry is Emergent Biosolutions Inc EBS, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.3% per year.
These 7 were selected because of their superior potential for immediate breakout.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Emergent Biosolutions Inc. (EBS): Free Stock Analysis Report
LogicBio Therapeutics, Inc. (LOGC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research